RFX6-mediated dysregulation defines human β cell dysfunction in early type 2 diabetes
Consortia: CBDS, CMAI, CTAR, HPAC
Walker. J.T. , D.C. Saunders, V. Rai, C. Dai, P. Orchard, A.L. Hopkirk, C.V. Reihsmann, Y. Tao, S. Fan, S. Shrestha, A. Varshney, J.J. Wright, Y.D. Pettway, C. Ventresca, S. Agarwala, R. Aramandla, G. Poffenberger, R. Jenkins, N.J. Hart, D.L. Greiner, L.D. Shultz, R. Bottino, J. Liu, S.C.J. Parker, A.C. Powers, and M. Brissova.
bioRxiv. 2021 Dec 17. DOI: 10.1101/2021.12.16.466282.